Table of Contents
Dr. Colleen Cutcliffe, CEO of Pendulum Therapeutics, is merging biotech rigor with consumer-friendly safety to tackle type 2 diabetes before it even starts.
Pendulum - who've raised $150M and have early backing from Mayo Clinic - have a flagship medical food named Pendulum Glucose Control, which is clinically proven to lower A1C. Just ask Halle Berry, who saw her own levels drop and came on board as an investor after it helped her diabetes!
I had the pleasure of catching up with Colleen at JPM Week 2025.
Yours sincerely,
Dr. Adil Ali
